NCT00596518View on ClinicalTrials.gov

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

PF-00734200

The drug is administered as a single dose of four 5-mg tablets

Trial Locations (4)

32809

Pfizer Investigational Site, Orlando

33169

Pfizer Investigational Site, Miami

37920

Pfizer Investigational Site, Knoxville

55404

Pfizer Investigational Site, Minneapolis

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY